Imugene Stock Current Ratio
| IMU Stock | 0.04 0 2.56% |
Imugene fundamentals help investors to digest information that contributes to Imugene's financial success or failures. It also enables traders to predict the movement of Imugene Stock. The fundamental analysis module provides a way to measure Imugene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imugene stock.
Imugene | Current Ratio |
Imugene Company Current Ratio Analysis
Imugene's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Imugene has a Current Ratio of 0.0 times. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Imugene Fundamentals
| Return On Equity | -0.97 | ||||
| Return On Asset | -0.51 | ||||
| Operating Margin | 22.86 % | ||||
| Current Valuation | 195.99 M | ||||
| Shares Outstanding | 7.57 B | ||||
| Shares Owned By Insiders | 14.38 % | ||||
| Shares Owned By Institutions | 6.60 % | ||||
| Price To Book | 2.43 X | ||||
| Price To Sales | 59.38 X | ||||
| Revenue | 4.97 M | ||||
| Gross Profit | 11.78 M | ||||
| EBITDA | (147.98 M) | ||||
| Net Income | (149.68 M) | ||||
| Cash And Equivalents | 49.54 M | ||||
| Total Debt | 1.55 M | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (97.32 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.3 | ||||
| Beta | 3.34 | ||||
| Market Capitalization | 295.12 M | ||||
| Total Asset | 151.4 M | ||||
| Retained Earnings | (289.83 M) | ||||
| Working Capital | 83.74 M | ||||
| Net Asset | 151.4 M |
About Imugene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imugene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imugene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imugene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.